Drug Maker
639 posts

Drug Maker
@drugmaker101
Organic Chemist | Drug Hunter and Developer | Soccer fan | Investing Beginner
Katılım Ağustos 2014
296 Takip Edilen69 Takipçiler
Drug Maker retweetledi
Drug Maker retweetledi
Drug Maker retweetledi

Here's how to construct a portfolio to capitalize on the second stage of the AI revolution -- which is centered around enterprise software 👇
• AI & Cloud Infrastructure | $MSFT, $GOOGL, $AMZN, $ORCL, $IBM, $DOCN
• Data, Analytics, & AI Platforms | $SNOW, $DDOG, $ESTC, $MDB, $PLTR, $PATH, $CFLT, $DT
• Enterprise Software & Services | $CRM, $HUBS, $NOW, $TEAM, $PAYC, $GTLB, $KVYO, $PD
• Cybersecurity & Web Services for AI | $CRWD, $ZS, $PANW, $FTNT, $OKTA, $NET
• Specialized & Emerging Tech | $META, $LMND, $RXRX, $ABCL, $SDGR
English

@sparkle6193920 Thanks a lot for your call on SQ today. Was able to grab a few calls. Hope to see it go over $80 in a few weeks.
English
Drug Maker retweetledi
Drug Maker retweetledi

I made $2M from $8k in 2023, here are my top 60 tokens for 2024 bull run:
➮ AI: $TAO, $AGRS, $PAAL, $RNDR, $AKT, $FET, $PRIME, $AIOZ, $ORAI, $ABT, $ALEPH, $GHX, $AIT, $OPSEC, $NMT
➮ DePin: $FIL, $RNDR, $HNT, $THETA, $OCEAN, $ANKR, $HONEY
➮ L1: $KAS, $INJ, $KUJI, $MONAD, $ASTR, $RON, $SUI, $SEI
➮ GameFi: $MAVIA, $RON, $GALA, #BIGTIME, $ALICE, $MAGIC, $WILD, $SIDUS
➮ RWA: $SNX, $MKR, $CFG, $RBN, $POLYX
➮ L2: #STRK, #ARB, #METIS, #BOBA, #IMX
➮ BRC-20: $SAVM, #MUBI, #ORDI
➮ Modular: #TIA, #DYM, #GEL
Restaking : #RSTK, #EIGEN
Derivatives : #MCB, #AEVO, #DYDX
Here are some threads with tokens and details for each narrative 👇🧵

English
Drug Maker retweetledi
Drug Maker retweetledi

These 27 stocks are estimated to grow revenue, EPS & FCF at a min. CAGR of 15% over the next 3 years! Criteria:
- Mcap >10B
- Revenue, EPS & FCF next 3Y >15%
- FCF+
- Altman Z >1.80
1. $NVDA - Nvidia - $1,795B
2. $TSLA - Tesla - $638B
3. $TSM - Taiwan Semiconductor - $577B
4. $NVO - Novo Nordisk - $547B
5. $AMD - AMD - $286B
6. $UBER - Uber - $167B
7. $NOW - ServiceNow - $160B
8. $PANW - Palo Alto Networks - $116B
9. $WDAY - Workday - $80B
10. $CRWD - Crowdstrike - $80B
11. $SNOW - Snowflake - $77B
12. $CSU - Constellation Soft - $58B
13. $SMCI - Super Micro Comp - $56B
14. $PLTR - Palantir - $55B
15. $TEAM - Atlassian - $55B
16. $ADYEN - Adyen - $49B
17. $DXCM - Dexcom - $45B
18. $DDOG - Datadog - $43B
19. $SQ - Block - $43B
20. $ZS - Zscaler - $38B
21. $LI - Li Auto - $31B
22. $AXON - Axon - $20B
23. $CELH - Celsius Holdings - $14.7B
24. $ESTC - Elastic - $13.2B
25. $KOG - Kongsberg Gruppen - $10.9B
26. $CYBR - Cyberark Software - $10.8B
27. $FIVE - Five Below - $10B
Source: @KoyfinCharts
Which of these high growth stocks do you hold in your portfolio?


English

@Banana3Stocks What do you think of ADBE? Down over 5% without any news.
English
Drug Maker retweetledi

If 🫵 you want to
Master Options Selling
you need to 📚 learn few key aspects of options trading 👇👇👇
Δ Delta
Delta of an option indicates how much the price of the option will change for every $1 movement in the price of the underlying asset
It's a measure of the sensitivity of the option's price to changes in the price of the underlying asset
Also it can be seen as Probability of particular strike expire in the money (ITM)
γ Gamma
Gamma is a measure of how much the delta of an option changes in response to a $1 change in the price of the underlying asset
In other words, gamma measures the rate of change of delta.
θ Theta
Theta, also known as time decay, is a measure of how much an option's price decreases as time passes and expiration approaches
It quantifies the rate of decline in the value of an option due to the passage of time.
Volatility
Higher volatility generally leads to higher options premiums because there is a greater likelihood of significant price movements in the underlying asset
Implied volatility (IV) is a measure of the market's expectation of future volatility of the underlying asset, as implied by the prices of options
When IV is high, options premiums are also high, reflecting the expectation of large price swings
Price action
Sudden and significant price movements against your expectation can result in rapid changes in options prices, leading to potential losses for option sellers who have sold options that become significantly in-the-money
Position Sizing
Position sizing is a fundamental risk management strategy that options sellers employ to safeguard their accounts from excessive losses, ensuring that even in the event of maximum loss, their accounts remain intact
If you found this helpful please FOLLOW, LIKE and REPOST
#Optionselling #OptionsTrading #options #StockMarket #tradingtips #optionseducation #callcreditspread #putcreditspread

English
Drug Maker retweetledi

@Banana3Stocks Thanks for the list. A must have in the bookmarks
English

$SPY $QQQ
“🍂☀️February☀️🍂” is short and sweet ❤️
Talk about asking to get my head chopped off to do a list in the literal midst of mega earnings season and the FOMC 🤯
I’m worried of a pullback in March, it could start mid to late February, on watch
But, here it goes…
$AAPL 🎯$195☀️🍂🍌
$AMZN 🎯$170☀️🍂🍌
$AFRM 🎯$47 ☀️🍂🍌
$AVGO 🎯$1235 ☀️🍂🍌
$ADBE 🎯$640 ☀️🍂🍌
$BABA 🎯$80 😡☀️🍂🍌
$CURE 🎯$118 ☀️🍂🍌
$DDOG 🎯$135 ☀️🍂🍌
$ENPH 🎯$125 ☀️🍂🍌
$KWEB 🎯$27 ☀️🍂🍌
$MARA 🎯$23 ☀️🍂🍌
$META 🎯$420 🌿💨 ☀️🍂🍌
$NFLX 🎯$585 ☀️🍂🍌
$NVDA 🎯$670 👀☀️🍂🍌
$PYPL 🎯$70 ☀️🍂🍌
$SHOP 🎯$88 ☀️🍂🍌
$TSLA 🎯$208 👀👀☀️🍂🍌
$TNA 🎯$41 ☀️🍂🍌
$XBI 🎯$96 ☀️🍂🍌
NOT FINANCIAL ADVICE OF ANY KIND! Much love!!!
❤️❤️❤️
🍌🍌🍌
🍂🍂🍂
☀️☀️☀️
GIF
English

@Banana3Stocks Agree. Considering the strong customer spending during the holiday season. Would expect a strong QR.
English


@Banana3Stocks Thanks for sharing. Wondering why $190? Bollinger Band low level? It's hard to tell from the 4 hr chart.
English

@RolfOptions Could you please give some examples? Personally I think TSLA is a bad choice for option selling due to its huge volatility.
English

There are some good stocks that are really bad choices for #Optionselling due to the nature of price action vs probabilities
There are some bad stocks that are really good choices for Options Selling due to the nature of price action vs probabilities
#options #income
English
Drug Maker retweetledi
Drug Maker retweetledi

🚨 Earnings Freebie - Netflix, Inc. ( $NFLX )
Before diving in, please note that my initial long thesis/position began from October 11, 2022 which is currently up +121.65% or +$265.06/share as of the close Friday.
If you find value here, please like❤️ & repost this to share and increase odds that we help someone else.
That said, Netflix is expected to release its earnings on Tuesday, Jan 23, after the market close. The consensus EPS estimated for the quarter is $2.20, against $0.12 YoY. Netflix, a prominent player in the streaming services sector, experienced a commendable growth of 48.5% in 2023. This momentum might extend into 2024 despite a stagnant start to the year. The company's financial strength and favorable historical market multiples suggest a promising outlook.
The company anticipates a 10.7% year-on-year revenue increase for Q4 2023, which would mark its highest quarterly growth in two years. This target, ambitious in light of post-pandemic slowdowns, is supported by initiatives like curbing password sharing, introducing advertisement-based and premium subscriptions, and hiking regular subscription rates.
These strategies bore fruit in Q3 2023, as Netflix reported a substantial surge in net paid additions (8.76 million) and a 10.8% growth in paid membership, the highest since Q1 2021. Despite the heightened competition, Netflix retained a significant lead in screen timeshare in its major US market.
However, these gains came with a caveat: a decrease in the average revenue per membership (ARM), which, at USD 34.56, was below the three-year average of around USD 35. To meet the revenue growth target, Netflix would need a membership growth rate matching the revenue increase of 10.7%, a challenging feat given the historical discrepancy between membership and revenue growth rates.
Looking at profitability, Netflix projects a Q4 2023 operating margin of 13.3%, down from 22.4% in Q3 2023. This decline is not alarming, considering the seasonal nature of Netflix's margins. Interestingly, the anticipated margin drop is less severe compared to previous years, potentially due to lower inflation and the effects of the Hollywood writers' strike. However, the resolution of this strike and the resulting cost implications could influence future profitability.
The Q4 2023 report will be pivotal in assessing Netflix's growth trajectory and profit potential. Even if the results don't meet expectations, the company's robust fundamentals and attractive market multiples suggest a significant stock upside. The forward price-to-earnings (P/E) ratio, projected at 39.43x based on anticipated revenue growth and operating margin, is considerably lower than the five-year average of 55.36x. Similarly, the trailing twelve-month (TTM) GAAP P/E stands at 48.19x against a five-year average of 66.38x.
Thus, while Netflix faces challenges in maintaining its revenue per membership and managing operational costs, its strong market position and strategic initiatives position it favorably for continued growth. Despite potential short-term uncertainties, the company's solid fundamentals and market valuation make it an attractive investment option.
Last week, the stock declined 1.87% to close at $482.95, above its D50SMA of $471.73. The weekly RSI at 61.6 suggests a bullish trend. It has support around $475, and if the price sustains above it, then it could be heading towards $486.21, $490, $495.37 (.618 fib level) and $500.79. The uptrend channel remains in tact after a major cup and handle breakout which started in November 2023.
Primary Sympathy Watches:
$DIS Walt Disney
$WBD Warner Bros. Discovery
$LYV Live Nation Entertainment
$WMG Warner Music Gr
$TME Tencent Music Enter Gr
Join today for real time updates and alerts: tr.ee/XT

English

@sparkle6193920 Hi Moni, could you please check the flow of NFLX? ER is coming for it. Thanks.
English










